Startups
As an industry leader, TCT provides high-quality Internet, phone, television and security options to our growing service area while keeping pace with cutting-edge technologies.
Overview
Employees
11-50
Founded date
1953
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 29, 2013 | Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push | Here’s how: Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The Super... |
| Nov 27, 2013 | Making the Most of Scientific Meetings – 5 Tips for Emerging Medtech Companies | By: Erin Warner, S2N Health I’ve attended at least three lifetime’s worth of trade shows and scientific meetings, both as an exhibitor and a hanger-on, and I still find myself wondering before each one whether it’s worth the time and money ... |
| Oct 30, 2013 | FDA device approval imminent? Impressive CoreValve data allows Medtronic to skip advisory panel | The FDA has determined it will conduct separate reviews for the Trial’s Extreme Risk and High Risk studies. Upon reviewing the CoreValve Trial’s results for extreme risk patients, the FDA has determined it has sufficient information to eval... |
| Oct 22, 2013 | 3-D St. Jude Medical launches technology that gives docs real-time, 360-degree view of arteries | St. Jude says it’s the only medical device company with all these tools available in an integrated platform. “It works by integrating both Fractional Flow Reserve (FFR) technology to measure blood flow blockage inside the coronary arteries ... |
| Apr 14, 2011 | CardiOx targets $3.5M series C, regulatory clearance by year’s end | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R... |
| Sep 24, 2010 | TCT 2010 roundup: Abbott keeps after Boston Scientific’s Taxus | Abbott (NYSE:ABT) kept up the pressure on Boston Scientific Corp. (NYSE:BSX) at a high-profile cardiology conference, releasing data from a pair of studies it says show that its Xience V drug-eluting stent is better than Boston Scientific’s... |
| Sep 22, 2010 | TCT 2010 roundup | A major battlefield in the stent wars opens again this week, as thousands of cardiologists and other healthcare providers flock to Washington, D.C., for the annual Transcatheter Cardiovascular Therapeutics conference. Medical device industr... |
| CardiOx targets $3.5M series C, regulatory clearance by year’s end | CardiOx is hoping to close a $3.5 million series C round of investment that would go toward commercializing its noninvasive test for holes in the heart. The Columbus, Ohio-area company is also looking to obtain European and U.S. regulatory ... | |
| Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push | TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized “super-saturated oxygen” (SSO2) offers a ... |
Show more
Reviews 0
FAQ about TCT
When was TCT founded?
TCT was founded in 1953.
What has the press written about TCT?
Parsers VC has collected 12 articles mentioning TCT, among them “Company with medtech to reduce infarct size in heart attack patients seeks $25M for final push” (Nov 29, 2013) and “Making the Most of Scientific Meetings – 5 Tips for Emerging Medtech Companies” (Nov 27, 2013).
Is TCT still active?
Yes, TCT is active; its latest activity on Parsers VC dates from Jan 9, 2014.